Belite Bio, Inc

NASDAQ:BLTE

Biotechnology

Healthcare
$156.23 +0.31%

+$0.46 today

Market cap
$6.29B
Beta
-1.24
P/E (TTM)
-65.9
EPS (TTM)
-$2.26
52W Low $56.10High $200.00

Volume 0.09M

Average 0.17M

BLTE Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Belite Bio, IncNASDAQ: BLTE

Stock-Based Compensation · Q2 FY2026 · quarter ended Jun 2026

Stock-based compensation outflow grows to $6.78K

Q2 FY2026 stock-based compensation was $6.78K, compared with $0 a year earlier. Trailing-twelve-month stock-based compensation was $45.7K. Over 3 fiscal years it compounded at +197.2% a year.

Context

  • Stock-based compensation increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly stock-based compensation holds near $6.78K or moves back toward the trailing-twelve-month quarterly average of $11.43K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$6.78K— QoQ
Last fiscal yearDec 2025
$38.92M+333.1% YoY
LTMJun 2026
$45.7K+408.5% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year+333.1%——
3-year CAGR+197.2%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
38.92M USD
Year-over-year change
+333.1%
4-year CAGR
+124.6%

Stock-Based Compensation vs competitors

How BLTE compares with its peers on the latest reported figures

  • BLTE's LTM Jun 2026 stock-based compensation of $45.7K is the smallest of the 6 companies compared; the peer median is $9.22M.
  • Its year-over-year change of +408.5% is the highest of 5, against a peer median of +19.0%.
  • Over three fiscal years its annual growth of +197.2% compares with a peer median of +6.8%.
BLTE Competitors Peer median
Stock-Based Compensation for BLTE and competitors
Company Period LTM YoY 3-year CAGR% of revenue
KODKodiak Sciences Inc.LTM Sep 2026$63.89M +17.9%-17.8%—
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$31.69M -0.5%+25.3%416.2%
OCGNOcugen, Inc.LTM Mar 2026$9.22M +22.1%-9.9%206.5%
IRDOpus Genetics, Inc.LTM Mar 2026$3.95M +20.1%+23.4%33.0%
KLRSKalaris Therapeutics IncLTM Mar 2026$638K ———
BLTEBelite Bio, IncLTM Jun 2026$45.7K +408.5%+197.2%—
Peer median (excluding BLTE) $9.22M+19.0%+6.8%206.5%

Competitors are the stored peer set for BLTE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(9.67M)(12.65M)(31.63M)(36.14M)(77.61M)
Depreciation & Amortization30K198K399K449K464K
Deferred Income Tax0(1.91M)(4.69M)00
Stock-Based Compensation1.53M1.48M3.82M8.99M38.92M
Change in Working Capital640K(491K)(2.43M)1.13M2.55M
Accounts Receivables0(32K)(72K)74K(66K)
Inventory00000
Accounts Payables00000
Other Working Capital640K(459K)(2.36M)1.06M2.62M
Other Non-Cash Items(8K)1.91M4.69M(3.66M)(1.31M)
Operating Cash Flow(7.47M)(11.46M)(29.84M)(29.23M)(36.99M)
Capital Expenditures(74K)(394K)(63K)(151K)(178K)
Acquisitions (Net)18K0000
Purchases of Investments000(188.27M)(451.99M)
Sales of Investments00077.84M147.07M
Other Investing Activities000(35K)0
Investing Cash Flow(56K)(394K)(63K)(110.57M)(305.11M)
Debt Repayment00000
Common Stock Issued(583K)37.99M77.19M42.24M292.86M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities0(1.03M)(1.23M)41.36M370.37M
Financing Cash Flow(583K)36.96M75.96M83.6M663.23M
Effect of Forex Changes(161K)(366K)9K(269K)117K
Net Change in Cash(8.27M)24.75M46.07M(56.48M)321.26M
Free Cash Flow(7.55M)(11.85M)(29.9M)(29.39M)(37.17M)

Belite Bio, Inc

NASDAQ:BLTE

Intrinsic Alpha fair value

Locked

Current Price

$156.23

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.